On the Diagnosing Dx podcast, Pictor Chief Commercial Officer Janine McMurdie—drawing on leadership roles at Amgen and Ion Torrent—explores why proteomics is emerging as the next wave in diagnostics. She details how Pictor’s fast, flexible, and affordable platform puts patients first, navigates an evolving regulatory landscape, and leverages optimism to accelerate a science‑led future of precision health. Tune in on YouTube, Spotify, or Apple Podcasts to hear the full conversation.
Learn More
In David Meltzer’s recent LinkedIn Live session (watch from 13:42), CEO Jamie Platt contrasts genomics with proteomics, explains why real‑time protein insights are the next frontier in precision health, and reflects on a career of billion‑dollar exits and purpose‑built teams—reinforcing Pictor’s momentum to deliver transformative global diagnostics.
Learn More
The July issue of the Carlsbad Business Journal features Pictor’s Carlsbad lab opening on its front page, spotlighting a pivotal milestone in our U.S. expansion and drive to advance proteomics‑powered diagnostics. The coverage, made possible through the support of the Carlsbad Chamber of Commerce, underscores our commitment to grow alongside the region’s vibrant life‑sciences community.
Learn More
Pictor celebrates senior leader Kate Rhodes’s inclusion in the Carlsbad Chamber of Commerce’s “50 Over 50 – Special Edition,” which honors professionals who continue to shape industry and community. The recognition highlights Kate’s decades‑long leadership, operational excellence, and lasting impact on both Pictor’s growth and the broader San Diego life‑sciences ecosystem.
Learn More
On the June 3, 2025 episode of Tacos & Tech, host Neal Bloom speaks with Pictor CEO Jamie Gibson about how real‑time protein diagnostics are changing healthcare. The conversation covers the shift from DNA‑based tests to fast, accessible proteomics, Pictor’s move to San Diego, and the leadership lessons driving the company’s mission to make diagnostics quicker, cheaper, and more personal.
Learn More
The San Diego Business Journal spotlighted Pictor’s non-invasive, saliva-based proteomics technology—capable of delivering results in just four hours. CEO Jamie Platt discussed securing $5M in seed funding, plans to raise a $30M Series A, and a partnership-driven revenue model aimed at accelerating affordable, high-throughput testing for both pharma and clinical labs across the United States.
Learn More
Clinical Lab Products featured Pictor’s establishment of its U.S. headquarters in San Diego, noting this pivotal move to scale operations across North America. The coverage underscores our accelerating growth strategy and invites industry partners and investors to join upcoming ribbon‑cutting and executive sessions as we advance accessible proteomics solutions.
Learn More
Yahoo Finance covered our new Carlsbad headquarters, $5 M seed funding, and plans to scale low‑cost, high‑throughput multiplex proteomics testing—capitalizing on a recent court decision that keeps lab‑developed tests under CLIA oversight and clears the path for rapid U.S. expansion.
Learn More
GenomeWeb, a leading genomics and diagnostics publication, covered Pictor’s move to establish its U.S. headquarters and close a $5 M seed round. The feature introduces our accessible proteomics platform to more than 100,000 life‑science professionals and signals the start of our next fundraising phase.
Learn More
Pictor, a global leader in multiplex proteomics solutions, is excited to announce the establishment of its U.S. headquarters in Carlsbad, California, marking a significant milestone in its strategic growth and commitment to delivering cutting-edge diagnostic capabilities to clinical laboratories worldwide.
Learn More
Get in touch with us to discuss partnerships, investment opportunities, or learn more about our platform.
For support, requests or inquiries info@PictorDx.com
